Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) were first detected
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …

The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in
research and clinical practice. Scientific advances in the past 7 years suggest that they might …

Objective To describe clinical and radiologic features associated with myelin
oligodendrocyte glycoprotein antibodies (MOG-Ab) in a large French nationwide adult …

Conformation-sensitive antibodies against myelin oligodendrocyte glycoprotein (MOG) are
detectable in patients with optic neuritis, myelitis, opticomyelitis, acute or multiphasic …

Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disorder that
preferentially affects the spinal cord and optic nerve. Most patients with NMOSD experience …

Objective: To describe the features of adult patients with benign, unilateral cerebral cortical
encephalitis positive for the myelin oligodendrocyte glycoprotein (MOG) antibody. Methods …

MOG antibody disease is an autoimmune disease of the central nervous system associated
with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a …

Myelin oligodendrocyte glycoprotein (MOG), a member of the immunoglobulin (Ig)
superfamily, is a myelin protein solely expressed at the outermost surface of myelin sheaths …

Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been found in
some cases diagnosed as seronegative neuromyelitis optica spectrum disorder (NMOSD) …

The clinical, pathological and therapeutic concepts of NMOSD have evolved and broadened
over the last two decades following the detection of AQP4 antibodies and MOG antibodies in …